Our New Office

We enjoyed meeting you.

We hope you had a chance to meet us.

The meeting was a great time of exchange and collaboration in Oman.

Did you know that in 2019, the combined Scope 1 and 2 greenhouse gas emissions from MetaSystems and MetaSystems Probes were equivalent to only 4.1 average German individuals? Moreover, this emissions figure dropped to a mere 2.6 people equivalent in 2021. And in 2022, all the electricity consumed by MetaSystems and MetaSystems Probes was sourced from renewable energy reserves or was self-produced.

We celebrate the 1,000th SlideFeeder x80!

We have held this year's technical training for our distributors.

Internal Technical Training Complete!

MetaSystems Probes participated in the 35th Tumor Genetics Workshop 2023 (Tumorgenetische Arbeitstagung) in Rostock, Germany.

Our colleagues from MetaSystems LatAm welcomed Camila Venegas (from MICROX, Chile) and Alexander Romero Guzman (from KAIKA, Colombia) for an in-depth training in Buenos Aires.

MetaSystems India participated in a two-day hands-on FISH workshop on April 4-5.

Last week, MetaSystems India participated in a one-day hands-on FISH workshop.

The MetaSystems team is looking forward to 2023 with great enthusiasm.

Another exciting year is slowly coming to an end.

It was a great pleasure to meet our distributors from around the world for the 20th time.

October is Breast Cancer Awareness Month, and we have highlighted the automation of HER2 FISH microscopy.

Read how our collaboration with MLL Münchner Leukämielabor on AI-based chromosome analysis is reducing their turnaround time.

The case and image management software called Neon is an integrated part of Ikaros, the karyotyping software, and Metafer, the slide scanning software. We have highlighted some of the unique features of Neon.

Following a radiation accident, a rapid assessment of the dose received by victims is critical. Biological dosimetry allows a range of tests, many of which are based on microscopy, to provide a retrospective estimate of the dose received.

Our advanced deep learning algorithms in Ikaros simplify the entire preparation process for karyotype analysis, from chromosome separation to classification. Read our article on AI-driven Intelligent Karyotyping with Ikaros.

We are following the current events in Ukraine with great concern. We have therefore decided to suspend our deliveries to Russia until further notice.

After becoming aware of the security vulnerability in the Java library Log4j, we immediately investigated the matter. After a careful review, we can inform you that MetaSystems’ software is not affected by the Log4j security gap.

Automate and standardize forensic sperm detection with the help of artificial intelligence! Meet us at EAFS 2022 in Stockholm.

The congress is intended for laboratory professionals from biomedical laboratory scientists, chemists, and physicians to microbiologists, geneticists, etc., and also product importers and manufacturers in the field.

Last Friday, 05/28/2021, we noticed a criminal attack on MetaSystems accounts. As a result, the attackers sent eMails that appeared to have been written and sent by MetaSystems employees. Please note that these mails were not sent by MetaSystems!

Artificial intelligence opens entirely new horizons for image analysis. In the latest versions of Ikaros, MetaSystems has implemented Deep Neural Network (DNN) based artificial intelligence that greatly facilitates the processing of metaphase images for karyotyping. MetaSystems is proud to announce that our innovative DNN-based technology has now received a patent entitled ‘Methods for Automated Chromosome Analysis’” (U.S. patent no. 10,991,098).

Theresia Bauer, Minister of Science, Research and the Arts for the State of Baden-Württemberg, Germany visited MetaSystems to get an impression of the work of this 'Hidden Champion' in life sciences sector.

Researchers led by dermatologist Raffaele Gianotti of the University of Milan and pathologist Prof. Massimo Barberis, director of the Molecular Pathology Unit at Institute of European Oncology in Milan, report evidence of early SARS-CoV-2 infection in an Italian patient.